Private Advisory Group’s Amedisys AMED Stock Holding History

Private Advisory Group’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-9,407	Closed	-$1.04M	–	126
2018 Q3	$1.04M	Buy	+9,407	New	+$1.04M	0.53%	59

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Private Advisory Group's AMED Position: Q4 2018 in Review

Private Advisory Group sold out of Amedisys (AMED) in Q4 2018, closing a stake of 9,407 shares — an estimated $1.04M sold.

Private Advisory Group first reported a position in AMED in Q3 2018 and held it in 1 quarter. The position peaked at $1.04M in Q3 2018. 297 funds tracked by Wall St. Rank hold AMED as of Q4 2018.

Private Advisory Group reported no remaining Amedisys position as of Q4 2018 after selling out during the quarter.
Private Advisory Group sold 9,407 Amedisys shares in Q4 2018, an estimated $1.04M.
Private Advisory Group first reported a position in Amedisys in Q3 2018 and held it in 1 quarter.
Private Advisory Group's Amedisys position peaked at $1.04M in Q3 2018.
297 funds tracked by Wall St. Rank held Amedisys as of Q4 2018.

Based on Private Advisory Group's 13F filing for Q4 2018, filed 11 Feb 2019.